Alexander Fleming

CABA, BS 1426

0 studies enrolling now · 2 studies all time

What they study most

Advanced Cancer, Biliary Tract Cancer, Metastatic Cancer, Soft Tissue Sarcoma

Studies at this site

• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma — Completed